# Oncoliq: Early Breast Cancer Detection Based on Liquid Biopsies and microRNAs

> **NCT06439940** · — · RECRUITING · sponsor: **Oncoliq US Inc** · enrollment: 364 (estimated)

## Conditions studied

- Breast Cancer Female
- Breast Cancer
- Breast Carcinoma

## Interventions

- **DIAGNOSTIC_TEST:** Blood sample extraction

## Key facts

- **NCT ID:** NCT06439940
- **Lead sponsor:** Oncoliq US Inc
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2021-07-14
- **Primary completion:** 2024-12-31
- **Final completion:** 2025-03-31
- **Target enrollment:** 364 (ESTIMATED)
- **Last updated:** 2024-06-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06439940

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06439940, "Oncoliq: Early Breast Cancer Detection Based on Liquid Biopsies and microRNAs". Retrieved via AI Analytics 2026-07-05 from https://api.ai-analytics.org/clinical/NCT06439940. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*